NASDAQ:NTRA 5 May 2026 - 20 June 2026

For live price, interactive charts, financials and the latest market data, visit Google Finance.

ADTX shares climb ahead of holiday as insider sales, Nasdaq listing pressure linger

Aditxt, Inc. jumped ahead of the Juneteenth holiday, with shares among the most heavily traded on Thursday’s Nasdaq. The microcap health innovation firm saw big volume, records showed, though new filings revealed some major holders were selling.

20 June 2026

Nasdaq·NASDAQ:ADTX·NASDAQ:GH·NASDAQ:NTRA·Stock Market

Natera Scores Rare FDA Approval but Shares Drop

Natera shares dropped Friday, even after its Signatera cancer test cleared a major U.S. regulatory hurdle. Some traders were moving out of healthcare growth stocks ahead of the weekend, which weighed on the stock.

16 May 2026

Biotechnology·Health News·NASDAQ:NTRA·Stock Market

GeneDx Stock Crash: WGS Plunges After Guidance Cut Raises Reimbursement Fears

Shares of GeneDx Holdings Corp. fell sharply Tuesday. The genetic testing company slashed its 2026 revenue outlook, overshadowing what had been a strong quarter for test-volume growth and putting fresh pressure on Wall Street’s view of the stock.

5 May 2026

Biotechnology·NASDAQ:GH·NASDAQ:ILMN·NASDAQ:NTRA·Stock Market

Go toTop